GVR Report cover Over-the-Counter (OTC) Analgesics Market Size, Share & Trends Report

Over-the-Counter (OTC) Analgesics Market Size, Share & Trends Analysis Report By Drug Type (Acetaminophen, NSAIDs, Salicylates), By Distribution Channel, By Region, And Segment Forecasts, 2023 To 2030

  • Report ID: GVR455374
  • Number of Pages: 0
  • Format: Electronic (PDF)

Over-the-counter (OTC) analgesics are easily accessible medications purchased without a prescription to relieve pain and reduce fever. They are commonly used for mild to moderate pain symptoms like headaches, muscle aches, toothaches, menstrual cramps, and minor injuries. OTC analgesics work by targeting ache receptors and reducing the production of prostaglandins, which transmit signals. The most common types include nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen.

NSAIDs like ibuprofen and naproxen sodium have pain-relieving and anti-inflammatory properties, while acetaminophen primarily targets aches and fevers. OTC analgesic drugs are available in various forms and come with dosage instructions. It is important to use them as directed, consult a healthcare professional if needed, and adhere to precautions for safe and appropriate usage.

According to the Centers for Disease Control and Prevention in 2021, the prevalence of chronic pain in the United States is significant, with an estimated 20.9% of adults experiencing chronic pain and 6.9% experiencing high-impact chronic aches. With a growing aging population, the demand for pain relief solutions is increasing as older individuals are more susceptible to chronic aches.

The expanding geriatric population faces various age-related issues, leading them to prefer home-based treatments over hospital visits. This trend escalates the market's importance and adoption of over-the-counter analgesic products. Basic OTC analgesics have been trusted and used by older patients for years, consistently maintaining high demand in the market. These factors contribute to the rising significance of OTC analgesics, offering accessible and self-administered discomfort relief options to individuals seeking to manage their pain independently. To meet this demand is the launch of Tylenol Rapid Release Gels by Johnson & Johnson Consumer Health in the United States in April 2022. This product offers fast-acting relief for various types of pain, addressing the growing need for convenient and effective OTC analgesics.

North America dominates the over-the-counter analgesics market due to several factors, such as the region's large consumer base and high demand for ache relief products. The prevalence of chronic pain conditions, an expanding aging population, and a culture of self-medication drive this demand. OTC analgesics provide convenient and accessible solutions for individuals managing chronic pain without a prescription. The demand for OTC analgesics remains consistently high, with a growing number of older adults more susceptible to chronic pain.

Additionally, major pharmaceutical companies and retail chains in North America ensure the widespread availability of OTC analgesics through various distribution channels. Furthermore, the region's well-established regulatory frameworks, such as the U.S. FDA, ensure the safety and efficacy of OTC analgesics, enhancing consumer trust. These factors, including the prevalence of chronic pain conditions, an aging population, strong market players, and supportive regulations, contribute to dominance in the market.

Over-the-counter Analgesics Market Segmentation

Report Attribute


Drug Type

Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics

By Distribution Channel

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Major companies operating in the glaucoma market include Bayer AG, Boehringer Ingelheim International GmbH, Johnson & Johnson Services Inc, GSK plc, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, AstraZeneca, Merck & Co Inc. These players focus on geographical expansion and product launches to maintain their presence in the market.

For instance, in March 2023, US FDA announced the approval of Narcan, and to be made available OTC without prescription. Narcan is used to reverse the effects caused by an overdose of opioids rapidly and is deemed the standard treatment for such emergencies. This decision allows for the direct sale of this drug to consumers in various retail locations, including drug stores, gas stations, grocery stores, convenience stores, and online platforms. These alternative uses of analgesics are anticipated to improve the revenue-generating ability of the market further.

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.